Long-Term Survival in a Patient With Ruptured Hepatocellular Carcinoma
3
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
A 57-yr-old woman previously diagnosed with chronic hepatitis B was admitted via the emergency room because she suddenly developed epigastric pain with abdominal distension. On computed tomography (CT), around enhancing mass was found on the left hepatic lobe with ascites in the peritoneal space. Bloody ascites were found upon tapping the ascites, and this led to the diagnosis of ruptured hepatocellular carcinoma (HCC). The patient was immediately treated with transcatheter arterial chemoembolization (TACE) including 50 mg of adriamycin and 10 mL of lipiodol, and then we performed left lateral segmentectomy 20 days later. To prevent recurrence of HCC by any micrometastasis, the patient subsequently received 8 cycles of adjuvant systemic chemotherapy (a regimen of epirubicin (50 mg/m2), cisplatin (60 mg/m2) and 5-fluorouracil (200 mg/m2)) atmonthly intervals. After this, the patient has been regularly followed up and she shows no signs of tumor recurrence 7 years later. This case suggests that surgical resection and subsequent adjuvant systemic chemotherapy with using an ECF regimen may provide long-term survival for patients ruptured HCC.
Abstract
A 57-yr-old woman previously diagnosed with chronic hepatitis B was admitted via the emergency room because she suddenly developed epigastric pain with abdominal distension. On computed tomography (CT), around enhancing mass was found on the left hepatic lobe with ascites in the peritoneal space. Bloody ascites were found upon tapping the ascites, and this led to the diagnosis of ruptured hepatocellular carcinoma (HCC). The patient was immediately treated with transcatheter arterial chemoembolization (TACE) including 50 mg of adriamycin and 10 mL of lipiodol, and then we performed left lateral segmentectomy 20 days later. To prevent recurrence of HCC by any micrometastasis, the patient subsequently received 8 cycles of adjuvant systemic chemotherapy (a regimen of epirubicin (50 mg/m2), cisplatin (60 mg/m2) and 5-fluorouracil (200 mg/m2)) atmonthly intervals. After this, the patient has been regularly followed up and she shows no signs of tumor recurrence 7 years later. This case suggests that surgical resection and subsequent adjuvant systemic chemotherapy with using an ECF regimen may provide long-term survival for patients ruptured HCC.
참고문헌 (13)
- "Korea National Statistical Office (KNSO)"[URL]
- Ong GB, "Spontaneous rupture of hepatocellular carcinoma", Br Med J, 4, pp.146~149 (1972)
- Chearanai O, "Spontaneous rupture of primary hepatoma: report of 63 cases with particular reference to the pathogenesis and rationale treatment by hepatic artery ligation", Cancer, 51, pp.1532~1536 (1983)
- Clarkston W, "Acute hemoperitoneum from rupture of a hepatocellular carcinoma", J Clin Gastroenterol, 10, pp.221~225 (1988)
- Buczkowski AK, "Multidisciplinary management of ruptured hepatocellular carcinoma", J Gastrointest Surg, 10, pp.379~386 (2006)
- Yeh CN, "Spontaneous tumour rupture and prognosis in patients with hepatocellular carcinoma", Br J Surg, 89, pp.1125~1129 (2002)
- Liu CL, "Management of spontaneous rupture of hepatocellular carcinoma: single-center experience", J Clin Oncol, 19, pp.3725~3732 (2001)
- Terada T, "Spontaneous rupture of peripancreatic lymph node with hepatocellular carcinoma metastasis: report of an autopsy case with massive peritoneal bleeding", Hepatol Res, 26, pp.73~76 (2003)
- Choi BG, "The findings of ruptured hepatocellular carcinoma on helical CT", Br J Radiol, 74, pp.142~146 (2001)
- 민현주, "자연적 파열을 동반한 간세포암의 임상적 고찰", 대한소화기학회지, 44(3), pp.160~167 (2004), 대한소화기학회
- Chou YH, "Some unusual complications of malignancies: case 1. spontaneous rupture of hepatocellular carcinoma demonstrated by contrastenhanced sonography", Clin Oncol, 20, pp.4108~4111 (2002)
- Lai EC, "Spontaneous ruptured hepatocellular carcinoma: an appraisal of surgical treatment", Ann Surg, 210, pp.24~28 (1989)
- Jang JW, "Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5- fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma", Chemother Pharmacol, 54, pp.415~420 (2004)